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Abstract
Background: Cerebellar cortical degeneration (CCD) is an increasingly recognised neurodegenerative disease
process affecting many dog breeds. Typical presentation consists of a progressive cerebellar ataxia, with a variable
age at onset and rate of progression between different breeds. Cerebellar histopathological findings typically
consist of primary Purkinje neuronal degeneration and loss, with variable secondary depletion of the granular and
molecular cell layers. Causative genes have been identified associated with CCD in several breeds, allowing
screening for selective breeding to reduce the prevalence of these conditions. There have been no previous reports
of CCD in Hungarian Vizslas.
Results: Two full-sibling Hungarian Vizsla puppies from a litter of nine presented with a history of progressive
ataxia, starting around three months of age. Clinical signs included marked hypermetric and dysmetric ataxia,
truncal sway, intention tremors and absent menace responses, with positional horizontal nystagmus in one dog.
Routine diagnostic investigations were unremarkable, and magnetic resonance imaging performed in one dog
revealed mild craniodorsal cerebellar sulci widening, supportive of cerebellar atrophy. Owners of both dogs elected
for euthanasia shortly after the onset of signs. Histopathological examination revealed primary Purkinje neuron loss
consistent with CCD. Whole genome sequencing was used to successfully identify a disease-associated splice donor
site variant in the sorting nexin 14 gene (SNX14) as a strong causative candidate. An altered SNX14 splicing pattern
for a CCD case was demonstrated by RNA analysis, and no SNX14 protein could be detected in CCD case
cerebellum by western blotting. SNX14 is involved in maintaining normal neuronal excitability and synaptic
transmission, and a mutation has recently been found to cause autosomal recessive cerebellar ataxia and
intellectual disability syndrome in humans. Genetic screening of 133 unaffected Hungarian Vizslas revealed the
presence of three heterozygotes, supporting the presence of carriers in the wider population.
Conclusions: This is the first report of CCD in Hungarian Vizsla dogs and identifies a highly associated splice donor
site mutation in SNX14, with an autosomal recessive mode of inheritance suspected.
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Background
Cerebellar cortical degeneration (CCD) has been re-
ported in several different dog breeds [1–15], and is also
commonly referred to as cerebellar abiotrophy. CCD
typically causes slowly progressive clinical signs related
to diffuse cerebellar dysfunction, including a dysmetric
and hypermetric cerebellar ataxia, intention tremors,
menace response deficits and signs of central vestibular
dysfunction, including nystagmus and loss of balance
[12, 16]. Age of onset of clinical signs and the rate of
progression vary between breeds, ranging from neonatal,
as reported in Beagles and Rhodesian Ridgebacks [3, 13],
and early onset from weeks to months of age in the ma-
jority of breeds [2, 6, 8, 9, 14, 16], up to adult-onset at
months to years of age with a slower progression, seen
in Old English Sheepdogs, Gordon Setters and Scottish
Terriers [12, 15, 17].
Histopathological examination most often reveals a
primary diffuse loss of Purkinje neurons in the cerebellar
cortex, in some cases with milder secondary neuronal
depletion of the granular and molecular cell layers
[7, 11, 13, 14, 16]. Less commonly there have also been
reports of primary granular cell loss with sparing of the
Purkinje neuron layer in some dog breeds, including the
Border Collie and Bavarian Mountain Dog [6, 8], as well
as an immune-mediated granuloprival degeneration in the
Coton de Tulear [18]. Neurodegenerative lesions in some
dog breeds with CCD have been reported to also affect
areas of the central nervous system outside the cerebel-
lum, as seen in the Kerry Blue Terrier and Chinese-
Crested Dog [19, 20].
An autosomal recessive mode of inheritance for CCD
is suspected in most breeds, and putative causative gen-
etic mutations have been identified for CCD in several
of these [13–15, 21]. A mutation in the GRM1 gene was
identified as the cause of Bandera’s neonatal cerebellar
ataxia in the Coton de Tulear, which represents a func-
tional disturbance with minimal histopathological evi-
dence of CCD [21]. A recent study used genome-wide
mRNA sequencing to identify a causative mutation in
the β-III spectrin cytoskeletal protein gene, SPTBN2, in
Beagle dogs with neonatal CCD [13]. Genome-wide as-
sociation studies also recently identified a mutation in
the SEL1L gene, encoding a component of the endoplas-
mic reticulum-associated protein degradation machinery,
in Finnish Hounds with CCD [14], as well as a mutation
associated with adult-onset CCD in Gordon Setters and
Old English Sheepdogs in the autophagy gene, RAB24
[15]. This variation in clinical presentation, histopath-
ology and molecular findings suggests that CCD repre-
sents a heterogeneous disease process with varied
underlying genetic aetiologies in different dog breeds.
Following the diagnosis of CCD in two Hungarian Vizsla
(HV) littermates, the aim of this study was to describe the
clinical and histopathological features of CCD previously
unreported in this breed and to interrogate the genome of
an affected dog for potential causal mutations.
Methods
Clinical investigation
Two full-sibling HVs (Case 1 and 2) from a litter of nine
were presented separately to the Royal Veterinary College
(RVC), University of London for further investigation of
progressive ataxia and tremors. Clinical examinations and
diagnostic tests were performed at the RVC, with videos
obtained of both examinations. Whole blood was taken
ante-mortem from both dogs and stored for future mo-
lecular investigations. The dogs were both euthanased for
welfare reasons at their owners’ request, and submitted
for post mortem examination. Histopathological examin-
ation of the brain tissue was performed on both dogs.
Samples of cerebellar tissue from the male sibling (Case 1)
were obtained and stored in RNAlater medium to allow
subsequent RNA extraction. Relevant clinical history was
obtained where possible from the breeder regarding the
unaffected littermates, dam and sire.
Full post-mortem examination was performed in both
dogs, with samples of brain tissue preserved in 10 %
neutral buffered formalin followed by embedding in par-
affin wax. 4 μm thick sections were cut on a microtome
(Leica Jung RM2035) and stained with haematoxylin and
eosin. Slides were evaluated by a board-certified veterin-
ary pathologist (SLP), using light microscopy.
Molecular investigation
DNA was extracted from whole blood using the Nucleon
BACC2 DNA extraction kit (GE Healthcare Life Sciences).
RNA was extracted from canine cerebellum using the
Qiagen RNeasy midi kit (Qiagen), with on column DNase
treatment.
Whole genome resequencing of a single HV with CCD
(Case 2) was outsourced to the Wellcome Trust Centre
for Human Genetics, University of Oxford. Paired end
sequencing with a read length of 100 bp read generated
a dataset of approximately 75 Gb, resulting in ~30×
coverage of the genome. Reads were aligned to the
CanFam3.1 canine genome build using Burrows-Wheeler
Aligner (BWA) [22] and variants called using Genome
Analysis Toolkit (GATK) [23]. Variants were filtered based
on consequence predictions created using SNPeff [24],
and by comparison with variant calls generated for 13 un-
related genome sequences of other dog breeds.
A library for RNAseq was prepared using total RNA
extracted from Case 1. Messenger RNA was isolated
using Sera-Mag oligo(dT) magnetic beads, and libraries
prepared using the NEBNext® mRNA Sample Prep
Master Mix Set 1. The final RNA-seq library was quantified
by qPCR using the Kapa library quantification kit (Kapa
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Biosystems). Paired-end sequencing of 80 bp reads was
carried out on an Illumina MiSeq, producing an ~4Gb
dataset. Reads were aligned to the canine reference genome
(CanFam3.1) using BWA and further processed using
GATK. Aligned reads were viewed using The Integrative
Genomics Viewer (IGV).
Genotyping of the CCD associated variant was per-
formed using an allelic discrimination approach (Taqman),
using an ABI StepOne real-time thermal cycler. Primer
sequences were as follows: SNX14_F ATTACTGTA-
TATTGTGATCTCAAAGAAATGCTAATCT; SNX14_R,
AGCAAAAACGAGCAAAACAGACTTT; SNX14_V, VIC-
ACATTCCAGGTATAATATT-NFQ; SNX14_M FAM-
ACATTCCAGATATAATATT-NFQ.
Reverse transcription PCR was carried out in two
stages. Reverse transcription was performed using the
Qiagen Quantitect cDNA synthesis kit. PCR was per-
formed in 12 μl reactions consisting of 0.2 mM dNTPs
(NEB), 1× PCR buffer (Qiagen), 0.5 μM of each primer
(SNX14_x25F, CCGCTTGGTCTCACTCATAAC and
SNX14_x29_R, CACAATGTCCAATAAAACATAAGTCA),
0.5 units HotStarTaq plus DNA polymerase (Qiagen), and
template cDNA. Cycling parameters were 95 °C for 5 min,
followed by 35 cycles of 95 °C for 30 s, 57 °C for 30 s and
72 °C for 60 s, and a final elongation stage of 72 °C for
10 min. Sanger sequencing was performed using BigDye
v3.1 dye terminator chemistry.
For western blotting, cerebellum tissue from the affected
HV case and 6 unaffected control dogs (one each of the fol-
lowing breeds: Golden Retriever, Crossbreed, Beagle, Par-
son Russell Terrier, Great Dane and Labrador Retriever
cross) were first homogenized in lysis radioimmunopre-
cipitation assay buffer (RIPA, Sigma-Aldrich, R0278). 5 μl
(46–56 μg) of the total protein lysate was separated by 8 %
SDS-polyacrylamide gel electrophoresis. Proteins were then
transferred onto nitrocellulose membrane, and immuno-
blotting was performed using rabbit polyclonal anti-SNX14
antibody (1:500, Atlas Antibodies, HPA017639) and swine
polyclonal anti-rabbit antibody conjugated with horseradish
peroxidase (HRP) (1:1000, Daco, P0217). The protein bands
were detected using Novex ECL (Thermo Fisher Scientific)
HRP chemiluminescent substrate reagent kit (WP20005)
with high performance chemiluminescence film (Amersham
Hyperfilm ECL). To control for protein loading the same
protein lysates were used in the same quantities for a sep-
arate western blot using mouse monoclonal anti-beta
Actin antibody (1:1000, Abcam, mAbcam 8226) and goat
polyclonal anti-mouse antibody conjugated with HRP
(1:1000, Daco, P0447).
Results
Clinical investigation
Cases 1 (male) and 2 (female) both presented aged four
months old, having first demonstrated signs of ataxia
between two and three months of age. Until this time
they had developed the ability to walk at a similar rate
to their littermates. By four months of age the ataxia had
worsened and Case 1 had developed a marked head
tremor, more obvious with intention. The dogs were
otherwise bright and well, with normal behaviour re-
ported by their owners and no other clinical signs re-
ported. General physical examination was unremarkable
on presentation to the RVC. On neurological examin-
ation of both dogs, mentation was alert and appropriate.
They were both ambulatory with a markedly hypermet-
ric and dysmetric generalised cerebellar ataxia, with an
obvious intention tremor particularly when navigating
their environment and excited, both of which were more
exaggerated in Case 1. Paw positioning was intact, al-
though hopping responses showed a delayed onset of
limb protraction and exaggerated response in all limbs.
Spinal reflexes were intact in all four limbs. Cranial
nerve examination revealed absent menace responses bi-
laterally, with an intermittent positional horizontal nys-
tagmus in Case 2 when her head was elevated. No
hyperaesthesia was detected on spinal or cranial palpa-
tion. All other components of the neurological examin-
ation were within normal limits. These findings were
consistent with a diffuse and symmetrical lesion affecting
the cerebellum. Differential diagnoses included neurode-
generative disease, such as cerebellar cortical degener-
ation or lysosomal storage disorders, inflammatory/
infectious disease, metabolic disease and neoplasia. Diag-
nostic investigations were performed for Case 1 but not
Case 2, whose owners elected for euthanasia, with con-
sent for post-mortem examination. Haematology, serum
biochemistry and urinalysis in Case 1 revealed no signifi-
cant abnormalities for a four month-old dog. Blood
smear evaluation of leukocytes revealed no evidence of
intracellular storage vacuoles. Cranial magnetic reson-
ance imaging (MRI) revealed mildly increased width and
depth of the craniodorsal cerebellar sulci, with the im-
pression of a reduced volume of cerebellar grey matter
tissue in this region (Fig. 1). The gross size of the cere-
bellum otherwise appeared largely normal, with a mid-
sagittal cross-sectional brainstem to cerebellar area ratio
of 81.1 % [25]. There were also mildly enlarged cerebral
sulci and lateral ventricles, with the rest of the brain
MRI otherwise unremarkable. Cerebrospinal fluid (CSF)
sampled from the cerebellomedullary cistern was unre-
markable, with low nucleated cellularity and protein.
Based on the unremarkable blood tests, imaging findings
and clinical history, a presumptive diagnosis of CCD was
made. Following a deterioration in Case 1’s clinical signs
in the following weeks, his owners also elected for eu-
thanasia and consented to post-mortem examination.
There were no similar clinical signs reported in the lit-
termates or the parents of the affected HV siblings.
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On gross examination, in both dogs the cerebellum
appeared subjectively small relative to total brain size,
with bilaterally symmetrical atrophy of the cerebellar
hemispheres and a relative prominence of the cerebellar
vermis. On sagittal section the cerebellar folia were re-
duced in thickness in both dogs (Fig. 1). The resulting
diffuse widening of the cerebellar sulci was most prom-
inent in the dorsal and rostral vermis, with relative spar-
ing of the caudoventral lobules (Fig. 1). Microscopically,
in both dogs there was multifocally extensive loss of
cerebellar Purkinje neurons, which was particularly se-
vere in Case 1 (Fig. 2). Some Purkinje neurons remained
in Case 2 however they were frequently degenerate
(Fig. 3). In both dogs there was a marked depletion of
the granular cell layer, with a diffuse mild to moderate
gliosis, and atrophy of the molecular layer (Figs. 2 and
3). There were rare degenerate neurons and spheroid
formation in the cerebellar nuclei of Case 1. No evidence
of inflammation or neoplasia was seen and the gross and
histopathological examination of both dogs was other-
wise unremarkable, with no histological evidence of
intracellular material consistent with a lysosomal storage
product.
Genetic investigation
The entire genome of a single HV with CCD (Case 2) was
interrogated using a massively parallel sequencing ap-
proach. Paired end Illumina sequencing was performed to
give a final average coverage of 30× on alignment to the
canine genome sequence CanFam3.1. Variants identified
in the HV were compared with variants identified for 13
additional canine breeds. Based on the hypothesis that the
causal variant for CCD was rare and unique to the HV
dog breed, variants were filtered to only include ones that
were homozygous in the HV, and homozygous for the al-
ternative allele in the 13 other breeds. Of the remaining
variants 290 were predicted to either directly alter the
coding sequence of the protein or disrupt the transcript
Fig. 1 Cerebellar MRI and gross pathological specimen from an HV with CCD (Case 1). Midline sagittal T2-weighted MRI image (a), and fresh
sagittal section (b), of the cerebellum of a 4-month old HV with CCD. Predominantly affecting the rostral and dorsal cerebellum, there is widening
of the cerebellar sulci with increased cerebrospinal fluid (increased T2-weighted signal) between the folia and subjectively reduced cortical grey
matter (asterisks). This is not evident in the caudoventral lobules, which appear grossly normal (arrows)
Fig. 2 Histological findings in the cerebellar folia of an affected HV (Case 2, a) and a normal control dog (b). The affected HV (a) demonstrates
marked loss of Purkinje neurons (P), with an associated secondary depletion and thinning of the granular cell layer (G). The unaffected control
dog (b) cerebellar folium demonstrates the normal cellularity of the granular (G), Purkinje (P) and molecular (M) cell layers. (Haematoxylin and
eosin stain, ×100 magnification)
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sequence. A shortlist of 10 variants in potential candidate
gene was generated by performing an automated search of
the Online Mendelian Inheritance in Man database
(OMIM) for the gene names implicated by the 290 vari-
ants and the key word cerebellar ataxia. The 10 shortlisted
variants were individually considered by visually inspect-
ing genome sequence read alignments, strength of the
candidate gene, variant consequence (SIFT) and Case 1
genotype for each variant, established through an RNAseq
dataset. All shortlisted variants, including an initially com-
pelling variant in Ataxin1 (ATXN1), were excluded apart
from an exon 26 splice donor variant (CanFam3.1,
chr12:45,530,566, c.2653 + 1G >A) in the Sorting Nexin
14 (SNX14) gene; an excellent candidate causal variant
(Fig. 4). A summary of the shortlisted variants is shown in
the supporting information Additional file 1: Table S1.
The potential causal variant was further interrogated by
genotyping the second case and a set of 133 unaffected
HV as controls. The other CCD case (Case 1) was also
found to be homozygous for the disease-associated allele.
Of the controls, three heterozygotes were identified with
the remaining 130 HVs homozygous for the reference al-
lele. Of the three heterozygotes, two were half-siblings
and the other was unrelated at the parent level. Pedigree
information for the CCD cases was not available, but no
clinical signs were reported in either parent, supporting
carrier status.
The effect of the variant on the SNX14 transcript was
investigated by RT-PCR across the exon 26–27 junction,
using forward and reverse primers in exon 25 and 29 re-
spectively and cerebellar RNA from one CCD case (Case
1) and the six control dogs. A larger than expected PCR
product was seen for the CCD case (Fig. 5), with exon
26 in the case extending 275 bp to the position of an al-
ternative splice donor site, resulting in an aberrant string
of 15 amino acids and a premature stop codon
(p.G885Dfs*16) (Fig. 4). Western blot analysis using an
antibody targeting an amino acid sequence before the
splice variant, failed to identify SNX14 protein (either
full length or reduced) in cerebellum tissue of the CCD
case (Fig. 6).
Discussion
In this paper we present clinical, diagnostic, pathological
and genetic findings associated with, to our knowledge,
the first reported cases of CCD in HV dogs. We also re-
port the use of genome sequencing to successfully iden-
tify a disease-associated splice donor site variant in
Fig. 3 Cerebellar Purkinje neuron degeneration in an affected HV case (Case 2). Higher magnification of the cerebellar cortex in an affected HV
(a and b) reveals shrunken, angular and eosinophilic (degenerate) Purkinje neurons (arrows). Reduced cellularity of the granular cell layer (G) and
thinning and pallor of the molecular cell layer (M) are also evident, compared to the densely populated granular cell layer and normal molecular
cell layer in the unaffected control dog (c). (Haematoxylin and eosin stain, ×200 magnification)
Fig. 4 Splice donor mutation in CCD cases causing an altered splicing pattern. An exon 26 splice donor site mutation (GT > AT) causing exon 26
of SNX14 to extent by 275 additional nucleotides to an alternative splice donor site. The extended exon has a sequence of 15 aberrant amino
acids before a premature stop codon
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SNX14 as a strong candidate for CCD in the HV. An al-
tered SNX14 splicing pattern for a CCD case was dem-
onstrated by RNA analysis and no SNX14 protein could
be detected in CCD case cerebellum by western blotting.
The age of onset of clinical signs in the two reported
HV dogs is consistent with previous reports of canine
CCD in those breeds with a typically juvenile onset, with
most of these cases having an onset at around 3–4
months of age, and a relatively rapid progression over
several weeks to months [2, 6, 8, 9, 14, 16]. This is in
contrast to breeds where a neonatal, rapidly progressive
phenotype is seen, such as the Beagle and Rhodesian
Ridgeback [3, 13], and those with a later onset and more
slowly progressive condition typified by CCD in Gordon
Setters and Old English Sheepdogs [15]. Similar to re-
ports of canine CCD seen in other breeds [12, 16], the
observed clinical signs in the HV were referable to
diffuse cerebellar dysfunction, with both dogs displaying
a marked hypermetric, dysmetric ataxia, with marked
truncal sway and intention tremor, as well as bilateral
menace deficits with normal vision. Although they
remained ambulatory, both dogs demonstrated a pro-
gressive clinical course over a short period of around
two months, to the point that their owners elected for
euthanasia on humane grounds due to their poor quality
of life. This history of progression to euthanasia is typ-
ical of CCD in most breeds, apart from those with an
adult onset and slowly progressive CCD, whereby sur-
vival for years is possible [7, 12, 15].
Diagnostic investigations performed in Case 1 were
consistent with CCD, with MRI revealing widening of
sulci in the craniodorsal cerebellum suggesting atrophy
of cerebellar grey matter in this area (Fig. 1), similar to
previous MRI reports [5, 16, 25, 26]. The MRI scan per-
formed in this HV with CCD revealed a mid-sagittal
cross-sectional brainstem to cerebellar area ratio of
81.1 %, a value lower than a previously reported lower
limit of 89 % for the diagnosis of cerebellar atrophy
using MRI [25]. However, the 13 dogs used in that MRI
study consisted mainly of breeds with an adult onset,
slowly progressive form of CCD. The HV in the current
study also underwent MRI early in the disease, and
therefore given the variability in the time point in the
disease course at which MRI is performed, comparison
with dogs in the previous study is difficult. Given the
uncertainty regarding the length of time required for
cerebellar atrophy to be detectable on MRI in cases of
CCD [25], it is possible that MRI was performed in Case
1 before sufficient atrophy to cause a reduction in MRI
area ratio had developed.
Histopathological examinations in both dogs revealed
diffuse Purkinje neuron loss, with secondary depletion of
the granular cell layer, as well as reactive changes (glio-
sis) likely secondary to this degeneration of the Purkinje
neuron layer. These changes fit well with previous re-
ports of CCD or cerebellar abiotrophy, where primary
Purkinje neuron loss and secondary granular cell degen-
eration are most commonly reported [7, 11, 13, 14, 16].
Similar to previous studies, the HVs also demonstrated a
characteristic distribution of cerebellar folial atrophy,
with the dorsal and rostral vermis predominantly af-
fected whilst the caudoventral regions appeared spared
[10, 12, 14, 17]. Purkinje neuron loss and associated glio-
sis were more severe in Case 1. In addition Case 1 also
exhibited early neuronal degeneration within the cere-
bellar nuclei, which may be associated with the progres-
sion of clinical signs in this animal prior to euthanasia.
These microscopic changes were sufficient to cause mild
grossly observable symmetrical atrophy of the cerebellar
hemispheres and thinning of the cerebellar folia, consist-
ent with previous reports [1, 7, 16].
Fig. 5 Altered splicing pattern in a CCD case. Polymerase chain
reaction of cerebellar cDNA between exon 25 and 29 demonstrates
a product size increase of 275 bp for the CCD case (1) in comparison
to 6 control dogs (2–7) when visualised by agarose gel electrophoresis.
No template control (8)
Fig. 6 Western blot analysis of SNX14 protein. Western blot analysis
of SNX14 failed to detect protein in cerebellar tissue of the CCD
case (1). Presence of a band of expected size for SNX14 (110 kD)
was detected for 6 canine control cerebellar samples (2–7). ACTB
was used as a loading control
Fenn et al. BMC Genetics  (2016) 17:123 Page 6 of 8
Mutations in SNX14 have been reported to cause auto-
somal recessive cerebellar ataxia and intellectual disabil-
ity syndrome in humans [27]. In the first report of an
association between this syndrome and mutations in
SNX14, three distinct SNX14 mutations were identified
which segregated in three unrelated consanguineous
families, and included a nonsense mutation located in
exon 26 of SNX14. Interestingly SNX14 was investigated
in the third family purely based on phenotypic similar-
ities to the first two families. Full clinical signs included
intellectual disability, cerebellar ataxia, early-onset cere-
bellar atrophy, sensorineural hearing loss, and the dis-
tinctive association of progressively coarsening facial
features (broad face, fullness of the upper eyelid, broad
nasal base and slight underdevelopment of the alae,
broad and long philtrum, thick lower lip vermillion),
relative macrocephaly, and the absence of seizures. Fifth
finger brachycamptodactyly was also reported. There
were no obvious distinctive facial phenotypic differences
between CCD cases and unaffected HVs, and auditory
function was normal on examination. However, electro-
diagnostic tests of auditory function, such as brainstem
auditory evoked potentials, could be performed in future
studies to exclude a possible mild hearing loss. The in-
tellectual disability seen in humans with SNX14 muta-
tions was also not identified in the HVs with CCD,
although this is challenging to objectively evaluate in
dogs and may have developed at a later age. Marked
cerebellar ataxia and cerebellar atrophy with thinning of
the cerebellar folia on gross pathology were seen in HV
CCD cases, consistent with human cases.
SNX14 is a conserved 946 amino acid protein. In a
knockdown mouse model, SNX14 has been shown to be
involved in synaptic transmission and maintaining nor-
mal neuronal excitability [28]. Furthermore, using an in
vivo SNX14 translation blocking in a zebrafish model,
loss of neuronal tissue and reduced cerebellar area was
demonstrated, which could be rescued by co-injection
with the human SNX14 orthologue [29]. Cellular frac-
tionation experiments have shown SNX14 to be associ-
ated with the lysosomal fraction [29]. SNX14 has also
been shown to associate with the serotonin subtype 6 re-
ceptor, which has been implicated in cognition, anxiety
and learning and memory disorders, with SNX14 acting
as a negative regulator [30].
Although not directly examined, there were no re-
ported clinical signs in the remaining seven HV siblings
or the parents, supporting an autosomal recessive mode
of inheritance of the SNX14 mutation in the HV, as re-
ported in humans. Whilst we are not aware of any other
cases of CCD yet identified in other HV families, the
finding of three heterozygotes amongst the 133 un-
affected HV samples confirms the presence of carriers in
the wider HV population. As a result, genetic testing for
the SNX14 mutation could be beneficial both in support-
ing a presumptive antemortem diagnosis of CCD in an
HV with consistent clinical signs, as well as allowing
breeders to identify carriers.
Conclusion
This paper represents the first confirmed report of cere-
bellar cortical degeneration in two young HV dogs and
identifies a splice donor site mutation in SNX14 as the
likely cause, based on RNA analysis, protein analysis and
studies in other species and in vivo models. The identifi-
cation of this mutation will allow the development of a
genetic test to help to identify affected and carrier dogs,
to help to eliminate the disease from the breed.
Additional file
Additional file 1: Table S1. A summary of the 10 shortlisted variants in
potential candidate genes. (XLSX 14 kb)
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